Health In Tech Lowers FY2026 Sales Guidance from $33.000M to $30.000M vs $34.859M Est
Benzinga Newsdesk 2 days ago
NewsGuidance
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Health In Tech (NASDAQ:HIT) lowers FY2026 sales outlook from $33.000 million to $30.000 million vs $34.859 million estimate.
Health In Tech (NASDAQ:HIT) lowers FY2026 sales outlook from $33.000 million to $30.000 million vs $34.859 million estimate.